Detectability of hypometabolic regions in mild Alzheimer disease: function of time after the injection of 2-[fluorine 18]-fluoro-2-deoxy-D-glucose

S Sakamoto, K Ishii, K Hosaka, T Mori… - American journal …, 2005 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: 2-[Fluorine 18]-fluoro-2-deoxy-d-glucose (FDG) positron
emission tomography (PET) has played an important role in detecting hypometabolic …

Leading role of 18F-FDG-PET imaging in early diagnosis of Alzheimer's disease: an overview

E Cason, G Treglia, G Fagioli - Research and Reports in Nuclear …, 2011 - Taylor & Francis
Early detection of Alzheimer's disease (AD) is important to reveal preclinical pathological
alterations, to monitor disease progression, and to evaluate response to therapy. The study …

[18F]-FDG uptake in brain slices prepared from an aged mouse model of Alzheimer's disease using a dynamic autoradiography technique

H Maruyama, M Gomi, TT Lwin, A Yoneyama… - Annals of Nuclear …, 2024 - Springer
Abstract Objective 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography ([18F]-
FDG-PET) is a imaging modality that has been used to measure of glucose metabolism in …

Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization

A Küntzelmann, T Guenther, U Haberkorn, M Essig… - Neuroscience …, 2013 - Elsevier
Using [18F] fluorodeoxyglucose (FDG) positron emission tomography (PET) patients with
Alzheimer's disease show impairment of cerebral glucose metabolism in bilateral …

Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies

J Dukart, K Mueller, A Horstmann, B Vogt, S Frisch… - Neuroimage, 2010 - Elsevier
FDG-PET ([18F] fluorodeoxyglucose positron emission tomography) is frequently used to
improve the differential diagnosis of dementia. However, a fundamental methodological …

Comparison between global and cerebellar intensity normalization of FDG PET images in patients with mild cognitive impairment or Alzheimer's disease

T Guenther, A Küntzelmann, U Haberkorn… - …, 2011 - thieme-connect.com
Introduction:[18F] fluorodeoxyglucose (FDG) positron emission tomography (PET) is well-
established in the examination of cerebral glucose metabolism in mild cognitive impairment …

Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease: FDG-PET studies in MCI and AD

L Mosconi - European journal of nuclear medicine and molecular …, 2005 - Springer
The demographics of aging suggest a great need for the early diagnosis of dementia and
the development of preventive strategies. Neuropathology and structural MRI studies have …

[HTML][HTML] Effects of plasma glucose levels on regional cerebral 18F-fluorodeoxyglucose uptake: Implications for dementia evaluation with brain PET imaging

BL Viglianti, DJ Wale, T Ma, TD Johnson… - Biomedicine & …, 2019 - Elsevier
Purpose Hyperglycemia affects FDG uptake in the brain, potentially emulating Alzheimer's
disease in normal individuals. This study investigates global and regional cerebral FDG …

Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT

M Tripathi, M Tripathi, N Damle… - The …, 2014 - journals.sagepub.com
Positron emission tomography (PET) imaging with F-18 fluorodeoxyglucose (FDG) can be
used as a downstream marker of neuronal injury, a hallmark of neurodegenerative …

Amyloid load but not regional glucose metabolism predicts conversion to Alzheimer's dementia in a memory clinic population

L Frings, S Hellwig, T Bormann, TS Spehl… - European journal of …, 2018 - Springer
Purpose The value of imaging regional glucose metabolism with [18 F] FDG PET for the
prediction of progression from mild cognitive impairment (MCI) to Alzheimer's dementia (AD) …